Skip to content
Real-world effectiveness of nirmatrelvir–ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants
Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, School of Public Health
Go to Link
Archive

Citation

Wong, C. K. H., Lau, K. T. K., & Leung, G. M. (2023, June). Real-world effectiveness of nirmatrelvir–ritonavir against BA.4 and BA.5 omicron SARS-CoV-2 variants. The Lancet Infectious Diseases. Elsevier BV. http://doi.org/10.1016/s1473-3099(23)00056-7

Resource Type

ScholarlyArticle

Addition Details

Date:

2023-06-01

Category:

Research

Source URL:

http://dx.doi.org/10.1016/S1473-3099(23)00056-7